Statistics for ANI Pharmaceuticals (id:6506 ANIP)
Valuation metrics
Market cap
1.16B
Enterprise value
1.61B
Trailing P/E (ttm)
51.63
Forward P/E
9.99
PEG ratio
9.99
Price/Sales (ttm)
2.09
Price/Book (mrq)
2.66
Enterprise Value/Revenue
2.90
Enterprise Value/EBITDA
19.59
Overview
Shares outstanding
21.02M
Float
15.91M
Shares short
2.16M
% Held by insiders
0.11%
% Held by institutions
1.01%
Average volume (10 days)
307.00K
Average volume (90 days)
Price summary
52-Week low
48.20
52-Week high
70.81
52-Week change
6.15%
Beta
0.71
50-Day moving average
58.40
200-Day moving average
62.18
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
July 18th, 2013
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-1.28%
Operating margin
-7.34%
Operational effectiveness
Return on assets
1.25%
Return on equity
-1.60%
Income statement
Revenue (ttm)
28.92
Revenue per share (ttm)
28.92
Quarterly revenue growth (yoy)
Gross profit (ttm)
305.30M
EBITDA
109.16M
Net income to common (ttm)
-8,766,000.00
Diluted EPS (ttm)
-0.47
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
153.28M
Total cash per share (mrq)
7.85
Total debt (mrq)
632.31M
Total Debt/Equity (mrq)
146.78
Current ratio (mrq)
274.50%
Book value per share (mrq)
20.74
Cash flow
Cash flow statement
92.90M
Levered free cash flow (LFCF)
50.11M